DHF Banner Image



Bloodstream infections resulting from central lines are a significant and avoidable contributor to healthcare expense and patient mortality in the U.S. Preventing Central Line Associated Bloodstream Infections (CLABSI) represents significant potential cost savings, improvement in patient safety, and the ability to meet national goals for healthcare organizations.

The MSC CLABSI Prevention Quality Solution provides guidance on infection prevention, using a checklist, during both central line insertion and site management, according to the Institute for Healthcare Improvement recommendations and Centers for Disease guidelines. The CLABSI Prevention Quality Solution is authored by Dr. Bradford Winters from Johns Hopkins Medical Center.
Subscribe now to MSC for updates!


Using ultrasound guidance for central venous catheter insertion has been proven to improve first-attempt success rates, reduce complications and cost.
Treating a central line-associated bloodstream infection can incur up to $29,000 in additional healthcare costs.
The Centers for Medicare & Medicaid has listed vascular catheter-associated infections as ineligible for reimbursement
The Joint Commission has identified preventing CLABSI as a hospital national patient safety goal.


Medical Simulation Corporation’s course is designed to educate all healthcare providers on guidelines surrounding the prophylaxis and early recognition of CLABSI. Participants may include physicians, nurses, physician assistants, nurse practitioners and technologists.


Improve compliance with Central Line Bundle adherence, translating to improved patient outcomes and cost savings.
Increase provider competence and confidence in central line placement for improved clinical outcomes.
Improve Value-Based Purchasing and Hospital Acquired Conditions scores to achieve CMS incentives, avoid penalties and improve profitability.